Structural and energetic determinants of the S1-site specificity in serine proteases

European Journal of Biochemistry

Volumn 260, Issue 3, 1999, Pages 571-595

  Czapinska, Honorata ^b   Otlewski, Jacek ^a  

^a UNIVERSITY OF WROC AW   (Poland)

^b NONE

Author keywords

Enzyme specificity; Protein inhibitors; Proteolytic enzymes; Serine proteases; Specificity pocket

Indexed keywords

AZUROCIDIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 9A; CATHEPSIN G; COLLAGENASE; ELASTASE; KALLIKREIN; PROTEIN C; PROTEIN INHIBITOR; PROTEINASE; SERINE PROTEINASE; SUBTILISIN; THROMBIN; TRYPTASE;

AMINO ACID SEQUENCE; ENZYME SPECIFICITY; GENE MUTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION; THERMODYNAMICS;

AMINO ACID SEQUENCE; ANIMALS; CHYMOTRYPSIN; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN FOLDING; SERINE ENDOPEPTIDASES; SUBSTRATE SPECIFICITY;

EID: 0033559558     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00160.x     Document Type: Review

References (162)

1. Neurath, H. (1984) Evolution of proteolytic enzymes. Science 224, 350-357.
2. Liao, D., Breddam, K., Sweet, R.M., Bullock, T. & Remington, S.J. (1992) Refined atomic model of wheat serine carboxypeptidase II at 2.2 Å resolution. Biochemistry 31, 9796-9812.
3. Qiu, X., Culp, J.S., DiLella, A.G., Hellmig, B., Hoog, S.S., Janson, C.A., Smith, W.W. & Abdel-Meguid, S. (1996) Unique fold and active site in cytomegalovirus protease. Nature 383, 275-279.
4. Wang, J., Hartling, J.A. & Flanagan, J. (1997) The structure of CIpP at 2.3 Å resolution suggests a model for ATP-dependent proteolysis. Cell 14, 447-456.
5. Matthews, D.A., Smith, W.W., Ferre, R.A., Condon, B., Budahazi, G., Sisson, W., Villafranca, J.E., Janson, C.A., McElroy, H.E., Gribskov, C.L. & Worland, S (1994) Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell 77, 761-771.
6. Seemuller, E., Lupas, A., Stock, D., Lowe, J., Huber, R. & Baumeister, W. (1995) Proteasome from Thermoplasma acidophilum: a threonine protease. Science 268, 579-582.
7. Pereira, P.J.B., Bergner, A., Macedo-Ribeiro, S., Huber, R., Matschiner, G., Fritz, H., Sommehoff, C.P. & Bode, W. (1998) Human β-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 392, 306-311.
8. Zhou, G.W., Guo, J., Huang, W., Fletterick, R.J. & Scanlan, T.S. (1994) The three-dimensional structure of a catalytic antibody with the active site similarity to serine proteases. Science 265, 1059-1064.
9. Quemeneur, E., Moutlez, M., Charbonnier, J.-B. & Menez, A. (1998) Engineering cyclophilin into a proline-specific endopeptidase. Nature 391, 301-304.
10. Cavarelli, J., Prevost, G., Bourquet, W., Moulinier, L., Chevrier, B., Delagoute, B., Bilwes, A., Mourey, L., Rifai, S., Piemont, Y. & Moras, D. (1997) The structure of Staphylococcus aureus epidermolytic toxin A, an atypical serine protease, at 1.7 Å resolution. Structure 6, 813-824.
11. Wang, E.C.W., Hung, S.-H., Cahoon, M. & Hedstrom, L. (1997) The role of the Cys191-Cys220 disulfide bond in trypsin: new targets for engineering substrate specificity. Protein Eng. 4, 405-411.
12. Siezen, R.J. & Leunissen, J.A.M. (1997) Subtilases: the superfamily of subtilisin-like proteases. Protein Sci. 6, 501-523.
13. Bode, W., Papamokos, E. & Musil, D. (1987) The high resolution structure X-ray structure of the complex formed between subtilisin Carlsberg and eglin c, an inhibitor from the leech Hirudo medicinalis. Eur. J. Biochem. 166, 673-692.
14. McPhalen, C.A. & James, M.N.G. (1988) Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo. Biochemistry 27, 6582-9598.
15. Gron, H. & Breddam, K. (1992) Interdependence of the binding subsites in subtilisin. Biochemistry 31, 8967-8971.
16. McPhalen, C.A., Svendsen, I., Jonassen, I. & James, M.N.G. (1988) Crystal and molecular structure of chymotrypsin inhibitor 2 from barley seeds in complex with subtilisin Novo. Proc. Natl Acad. Sci. USA 82, 7242-7246.
17. Baker, D., Sohl, J.L. & Agard, D.A. (1992) A protein-folding reaction under kinetic control. Nature 356, 263-265.
18. Zhu, X., Ohta, Y., Jordan, F. & Inoye, M. (1989) Pro-sequence of subtilisin can guide the refolding of denatured subtilisin in an intermolecular process. Nature 339, 483-484.
19. Gallagher, T., Gilliand, G., Wang, L. & Bryan, P. (1995) The prosegment-subtilisin BPN′ complex: crystal structure of a specific 'foldase'. Structure 3, 907-914.
20. Shinde, U.P., Liu, J.J. & Inouye, M. (1997) Protein memory through altered folding mediated by intramolecular chaperones. Nature 389, 520-522.
21. Bone, R., Fujishige, A., Kettner, C.A. & Agard, D.A. (1991) Structural basis for broad specificity in α-lytic protease mutants. Biochemistry 30, 10388-10398.
22. Perona, J.J., Tsu, C.A., McGrath, M.E., Craik, C.S. & Fletterick, R.J. (1993) Relocating a negative charge in the binding pocket of trypsin. J. Mol. Biol. 230, 934-949.
23. Graham, L.D., Haggett, K.D., Jennings, P.A., LeBrocque, D.S., Whittaker, R.G. & Schober, P.A. (1993) Random mutagenesis of the substrate binding site of a serine protease can generate enzymes with increased activities and altered primary specificities. Biochemistry 32, 6250-6258.
24. Perona, J.J., Evnin, L.B. & Craik, C.S. (1993) A genetic selection elucidates structural determinants of arginine versus lysine specificity in trypsin. Gene 137, 121-126.
25. Sidhu, S.S. & Borgford, T.J. (1996) Selection of Streptomyces griseus protease B mutants with desired alterations in primary specificity using a library screening strategy. J. Mol. Biol. 257, 233-245.
26. Nienaber, V.L., Breddam, K. & Birktoft, J.J. (1993) A glutamic acid specific serine protease utilises a novel histidine triad in substrate binding. Biochemistry 32, 11469-11475.
27. Barbosa, J.A.R.G., Saldanha, J.W. & Garratt, R.C. (1996) Novel features of serine protease active sites and specificity pockets: sequence analysis and modelling studies of glutamate-specific endopeptidases and epidermolytic toxins. Protein Eng. 9, 591-601.
28. Lesk, A.M. & Fordham, W.D. (1996) Conservation and variability in the structures of serine proteinases of the chymotrypsin family. J. Mol. Biol. 258, 501-537.
29. Bode, W., Meyer, E. Jr & Powers, J.C. (1989) Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism based inhibitors. Biochemistry 28, 1951-1963.
30. Bode, W., Chen, Z., Bartels, K., Kutzbach, C., Schmidt-Kastner, G. & Bartunik, H. (1983) Refined 2 Å X-ray crystal structure of porcine pancreatic kallikrein A, a specific trypsin-like serine proteinase: crystallisation, structure determination, crystallographic refinement, structure and its comparison with bovine trypsin. J. Mol. Biol. 164, 237-282.
31. Fischer, D., Wolfson, H., Lin, S.L. & Nussinov, R. (1994) Three-dimensional, sequence order-independent structural comparison of a serine protease against the crystallographic database reveals active site similarities: Potential implications to evolution and to protein folding. Protein Sci. 3, 769-778.
32. Greer, J. (1990) Comparative modelling methods: application to the family of the mammalian serine proteases. Proteins: Struct. Funct. Genet. 7, 317-334.
33. Morreau, T. & Gauthier, F. (1996) Homology modelling of rat kallikrein rK9, a member of the tissue kallikrein family: implications for substrate specificity and inhibitor binding. Protein Eng. 9, 987-995.
34. Petersen, L.C., Birktoft, J.J. & Flodgaard, H. (1993) Binding of bovine pancreatic trypsin inhibitor to heparin binding protein/CAP37/azurocidin. Interaction between a Kunitz-type inhibitor and a proteolytically inactive serine proteinase homologue. Eur. J. Biochem. 214, 271-279.
35. Caldwell, J.W., Agard, D.A. & Kollman, P.A. (1991) Free energy calculations on binding and catalysis by α-lytic protease: The role of substrate size in P1 pocket. Proteins: Struct. Funct. Genet. 10, 140-148.
36. Rao, N.V., Wehner N.G., Marshall, B.C., Gray, W.R., Gray, B.H. & Hoidal, J.R. (1991) Characterization of proteinase 3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J. Biol. Chem. 266, 9540-9548.
37. Laskowski, M. Jr & Kato, I. (1980) Protein inhibitors of proteinases. Annu. Rev. Biochem. 49, 593-626.
38. Bode, W. & Huber, R. (1992) Natural protein proteinases inhibitors and their interaction with proteinases. Eur. J. Biochem. 204, 433-451.
39. Lu, W., Apostol, I., Qasim, M.A., Warne, N., Wynn, R., Zhang, W.L., Anderson, S., Chiang, Y.W., Ogin, E., Rothberg, I., Ryan, K. & Laskowski, M. Jr (1997) Binding of amino acid side chain to SI cavities of serine proteinases. J. Mol. Biol. 266, 441-461.
40. Kojima, S., Nishiyama, Y., Kumagai, I. & Miura, K. (1991) Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor. J. Biochem. 109, 377-382.
41. Polanowska, J., Krokoszynska, I., Czapinska, H., Watorek, W., Dadlez, M. & Otlewski, J. (1998) Specificity of human cathepsin G. Biochim. Biophys. Acta 1386, 189-198.
42. Delbaere, L.T.J. & Brayer, G.D. (1985) The 1.8 Å structure of the complex between chymostatin and Streptomyces griseus protease A. A model for serine protease catalytic tetrahedral intermediates. J. Mol. Biol. 183, 89-103.
43. Brady, K., Wei, A., Ringe, D. & Abeles, R.H. (1990) Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors. Biochemistry 29, 7600-7607.
44. Hughes, D.L., Sieker, L.C., Bieth, J. & Dimicoli, J.-L. (1982) Crystallographic study of the binding of a trifluoroacetyl dipeptide anilide inhibitor with elastase. J. Mol. Biol. 162, 645-658.
45. Wei, A.-Z., Mayr, I. & Bode, W. (1988) The refined 2.3 Å crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor. FEBS Lett. 234, 367-373.
46. Oleksyszyn, J. & Powers, J.C. (1994) Amino acid and peptide phosphonate derivatives as specific inhibitors of serine peptidases. Methods Enzymol. 224, 423-441.
47. Powers, J.C. & Kam, C.-M. (1994) Isocoumarin inhibitors of serine peptidases. Methods Enzymol. 244, 442-457.
48. Graf, L., Jansco, A., Szilagyi, L., Hegyi, G., Pinter, K., Naray-Szabo, G., Hepp, J., Medzihradszky, K. & Rutter, W.J. (1988) Electrostatic complementarity in the substrate binding pocket of trypsin. Proc. Natl Acad. Sci. USA 85, 4961-4965.
49. Evnin, L.B., Vasquez, J.R. & Craik, C.S. (1990) Substrate specificity of trypsin investigated by using a genetic selection. Proc. Natl Acad. Sci. USA 87, 6659-6663.
50. Bode, W., Walter, J., Huber, R., Wenzel, H.R. & Tschesche, H. (1984) The refined 2.2 Å X-ray crystal structure of the tertiary complex formed by bovine trypsinogen, valine-valine and the Arg15 analogue of bovine pancreatic trypsin inhibitor. Eur. J. Biochem. 144, 185-190.
51. Bolognesi, M., Gatti, G., Menegatti, E., Guarneri, M., Marquart, M., Papamokos, E. & Huber, R. (1982) Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 Å resolution. J. Mol. Biol. 162, 839-868.
52. Helland, R., Berglund, G.I., Andersen, O.A., Smalås, A.O., Willassen, N.P., Apostoluk, W. & Otlewski, J. (1998) High resolution crystal structures of three new trypsin-squash inhibitor complexes. Detailed comparison with other trypsins and their complexes. Acta Crystallogr. D55, 139-148.
53. Takeuchi, Y., Nonaka, T., Nakamura, K.T., Kojima, S., Miura, K.-I. & Mitsui, Y. (1992) Crystal structure of an engineered subtilisin inhibitor complexed with bovine trypsin. Proc. Natl Acad. Sci. USA 89, 4407-4411.
54. Graf, L., Craik, C.S., Roczniak, S., Fletterick, R.J. & Rutter, W.J. (1987) Selective alteration of substrate specificity by replacement of aspartic acid-189 with lysine in the binding pocket of trypsin. Biochemistry 26, 2616-2623.
55. Wilke, M.E., Higaki, J.N., Craik, C.S. & Fletterick, R.J. (1991) Crystallographic analysis of trypsin G226A. A specificity pocket mutant of rat trypsin with altered binding and catalysis. J. Mol. Biol. 219, 525-532.
56. Perona, J.J., Hedstrom, L., Wagner, R.L., Rutter, W.J., Craik, C.S. & Fletterick, R.J. (1994) Exogenous acetate reconstitutes the enzymatic activity of trypsin Asp189 Ser. Biochemistry 33, 3252-3259.
57. Caughey, G.H. (1995) Mast Cell Proteases in Immunology and Biology. Marcel Dekker, New York, USA.
58. Stubbs, M.T., Morenweiser, R., Sturzebecher, J., Bauer, M., Bode, W., Huber, R., Piechottka, G.P., Matschiner, G., Sommerhoff, C.P., Fritz, H. & Auerswald, E.A. (1997) The three-dimensional structure of recombinant leech-derived tryptase inhibitor in complex with trypsin. J. Biol. Chem. 272, 19931-19937.
59. Tsunasawa, S., Masaki, T., Hirose, M., Soejima, M. & Sakiyama, F. (1989) The primary structure and structural characteristics of Achromobacter lyticus protease I, a lysine-specific serine protease. J. Biol. Chem. 264, 3832-3839.
60. Sakiyama, F., Norioka, S., Ohta, S., Lim, S.-I., Shiraki, K., Katsuragi, N., Masaki, T., Katsube, Y., Kitagawa, Y. & Sushi, K. (1997) Structural basis for restricted substrate specificity and high catalytic potency of a lysylendopeptidase, Achromobacter protease I. In Trends in Protein Research (Legocki, A. & Soda, K., eds), pp. 79-84, Scientific Publishers Own, Poznan, Poland.
61. Norioka, S., Ohta, S., Ohara, T., Lim, S.-I. & Sakiyama, F. (1994) Identification of three catalytic triad constituents and Asp-225 essential for function of lysine-specific serine protease, Achromobacter protease I. J. Biol. Chem. 269, 17025-17029.
62. Bhoola, K.D., Figueroa, C.D. & Worthy, K. (1992) Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharm. Rev. 44, 1-80.
63. Fiedler, F. (1987) Effects of secondary interactions on the kinetics of peptide and peptide ester hydrolysis by tissue kallikrein and trypsin. Eur. J. Biochem. 163, 303-312.
64. Brillard-Bourdet, M., Moreau, T. & Gauthier, F. (1995) Substrate specificity of tissue kallikreins: importance of an extended interaction site. Biochim. Biophys. Acta 1246, 47-52.
65. Moreau, T., Brillard-Bourdet, M., Bouhnik, J. & Gautier, F. (1992) Protein products of the rat kallikrein gene family. J. Biol. Chem. 267, 10045-10051.
66. Chen, Z. & Bode, W. (1983) Refined 2.5 Å X-ray crystal structure of the complex formed by porcine kallikrein A and the bovine pancreatic trypsin inhibitor: crystallisation, Patterson search, structure determination, refinement, structure and comparison with its components and with the bovine trypsin-pancreatic trypsin inhibitor complex. J. Mol. Biol. 164, 283-311.
67. Wang, J., Chao, J. & Chao, L. (1992) Specificity determinants of rat tissue kallikrein by site-directed mutagenesis. Protein Eng. 5, 569-575.
68. Chagas, J.R., Portaro, F.C.V., Hirata, I.Y., Almeida, T.C., Juliano, M.A., Juliano, L. & Prado, E.S. (1995) Determinants of the unusual cleavage specificity of lysyl-bradikinin-releasing kallikreins. Biochem. J. 306, 63-69.
69. Bax, B., Blundell, T.L., Murray-Rust, J. & McDonald, N.Q. (1997) Structure of mouse 7S NGF: a complex of nerve growth factor with four binding proteins, Structure 5, 1275-1285.
70. Fujinaga, M. & James, M.N.G. (1987) Rat submaxillary gland serine protease tonin - Structure solution and refinement at 1.8 Å resolution. J. Mol. Biol. 195, 373-396.
71. Lottenberg, R., Hall, J.A., Blinder, M., Binder, E.P. & Jackson, C.M. (1983) The action of thrombin on peptide, p-nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction conditions. Biochim. Biophys. Acta 742, 539-557.
72. Bode, W., Turk, D. & Karshikov, A. (1992) The refined 1.9 Å X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry and structure-function relationships. Protein Sci. 1, 426-471.
73. Fenton, J.W. (1988) Thrombin bioregulatory functions. Adv. Clin. Enzymol. 6, 186-193.
74. Craik, C.S., Largman, C., Fletcher, T., Roczniak, S., Barr, P.J., Fletterick, R.J. & Rutter, W.J. (1985) Redesigning trypsin: alteration of substrate specificity. Science 228, 291-297.
75. Henriksen, R.A. & Mann, K.G. (1989) Substitution of valine for glycine-558 in the congenital dysthrombin Quick II alters primary substrate specificity. Biochemistry 28, 2078-2082.
76. van de Locht, A., Lamba, D., Bauer, M., Huber, R., Friedrich, T., Kroger, B., Hoffken, W. & Bode, W. (1995) Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin. EMBO J. 14, 5149-5157.
77. Engh, R., Brandstetter, H., Sucher, G., Eichinger, A., Baumann, U., Bode, W., Huber, R., Poll, T., Rudolph, R. & von der Saal, W. (1996) Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug design. Structure 4, 1353-1362.
78. van de Locht, A., Stubbs, M.T., Bode, W., Friedrich, T., Bollschweiler, C., Hoffken, W. & Huber, R. (1996) The ornithodorin-thrombin crystal structure, a key to the TAP enigma? EMBO J. 22, 6011-6017.
79. Morenweiser, R., Auerswald, E.A., van de Locht, A., Fritz, H., Sturzebecher, J. & Stubbs, M.T. (1997) Structure-based design of a potent chimeric thrombin inhibitor. J. Biol. Chem 272, 19938-19942.
80. Tsiang, M., Paborsky, L.R., Li, W.-X., Jain, A.K., Mao, C.T., Dunn, K.E., Lee, K.E., Matsumura, S.Y., Matteucci, M.D., Coutre, S.E., Leung, L.L.K. & Gibbs, C.S. (1996) Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo. Biochemistry 35, 16449-16457.
81. Le Bonniec, B.F. & Esmon, C.T. (1991) Glu-192→Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin. Proc. Natl Acad. Sci. USA 88, 7371-7375.
82. van de Locht, A., Bode, W., Huber, R., Le Bonniec, B.F., Stone, S.R., Esmon, C.T. & Stubbs, M.T. (1997) The thrombin E192Q-BPTI complex reveals gross structural rearrangements for the interaction with antithrombin and thrombomodulin. EMBO J. 16, 2977-2984.
83. Banner, D.W. (1997) The factor VIIa/tissue factor complex. Thromb. Haem. 78, 512-515.
84. Banner, D.W., D'Arcy, A., Chene, C., Winkler, F.K., Guha, A., Konigsberg, W.H., Nemerson, Y. & Kirchhofer, D. (1996) The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 380, 41-46.
85. Padmanabhan, K., Padmanabhan, K.P., Tulinsky, A., Park, C.H., Bode, W., Huber, R., Blankenship, D.T., Cardin, A.D. & Kisiel, W. (1993) Structure of the human des (1-45) factor Xa at 2.2 Å resolution. J. Mol. Biol. 232, 947-966.
86. Lapatto, R., Krengel, U., Schreuder, H.A., Arkema, A., de Boer, B., Kalk, K.H., Hol, W.G.J., Grootenhuis, P.D.J., Mulders, J.W.M., Dijkema, R., Theunissen, H.J.M. & Dijkstra, B.W. (1997) X-ray structure of anistasin at 1.9 Å resolution and its modelled complex with blood coagulation factor Xa. EMBO J. 17, 5151-5161.
87. Burgering, M.J.M., Orbons, L.P.M., van der Doelen, A., Mulders, J., Theunissen, H.J.M., Grootenhuis, P.D.J., Bode, W., Huber, R. & Stubbs, M.T. (1997) The second Kunitz domain of human tissue pathway inhibitor: cloning, structure determination and interaction with factor Xa. J. Mol. Biol. 269, 395-407.
88. Brandstatter, H., Kuhne, A., Bode, W., Huber, R., von der Saal, W., Wirthensohn, K. & Engh, R. (1996) X-ray structure of the active-site inhibited clotting factor Xa, J. Biol. Chem. 271, 29988-29992.
89. Brandstetter, H., Bauer, M., Huber, R., Lollar, P. & Bode, W. (1995) X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. Proc. Natl Acad. Sci. USA 92, 9796-9800.
90. Cho, K., Tanaka, T., Cook, R., Kisiel, W., Fujikawa, K., Kurachi, K. & Powers, J.C. (1984) Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thioester substrates. Biochemistry 23, 644-650.
91. Hopfner, K.-P., Brandstetter, H., Karcher, A., Kopetzki, E., Huber, R., Engh, R.A. & Bode, W. (1997) Converting blood coagulation factor IXa into factor Xa: dramatic increase in amidolytic activity identifies important active site determinants. EMBO J. 16, 6626-6635.
92. Esmon, C.T. (1989) The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264, 4743-4746.
93. Mather, T., Oganessyan, V., Hof, P., Huber, R., Foundling, S., Esmon, C. & Bode, W. (1996) The 2.8 Å crystal structure of Gla-domainless activated protein C. EMBO J. 15, 6822-6831.
94. Stone, S.R. & Hofsteenge, J. (1985) Specificity of activated human protein C. Biochem. J. 230, 497-502.
95. Rezaie, A.R. & Esmon, C.T. (1993) Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors. J. Biol. Chem. 268, 19943-19948.
96. Spraggon, G., Phillips, C., Nowak, U.K., Ponting, C.P., Saunders, D., Dobson, C.M., Stuart, D.I. & Jones, E.Y. (1995) The crystal structure of the catalytic domain of human urokinase-type plasminogen activator. Structure 3, 681-691.
97. Lamba, D., Bauer, M., Huber, R., Fischer, S., Rudolph, R., Kohnert, U. & Bode, W. (1996) The 2.3 Å crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator. J. Mol. Biol. 258, 117-135.
98. Renatus, M., Bode, W., Huber, R., Sturzebecher, J., Prasa, D., Fischer, S., Kohnert, U. & Stubbs, M.T. (1997) Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. J. Biol. Chem. 272, 21713-21719.
99. Renatus, M., Engh, R.A., Stubbs, M.T., Huber, R., Fischer, S., Kohnert, U. & Bode, W. (1997) Lysine 156 promotes the anomalous proenzyme activity of t-PA: X-ray crystal structure of single-chain human t-PA. EMBO J. 16, 4797-4805.
100. Renatus, M., Stubbs, M.T., Huber, R., Bringmann, P., Donner, P., Schleuning, W.-D. & Bode, W. (1997) Catalytic domain structure of vampire plasminogen activator: a molecular paradigm for proteolysis without activation cleavage. Biochemistry 36, 13483-13493.
101. Coombs, G.S., Dang, A.T., Madison, E.L. & Corey, D.R. (1996) Distinct mechanisms contribute to stringent substrate specificity of tissue-type plasminogen activator. J. Biol. Chem. 271, 4461-4467.
102. Ding, L., Coombs, G.S., Strandberg, L., Navre, M., Corey, D.R. & Madison, E.L. (1995) Origins of the specificity of tissue-type plasminogen activator. Proc. Natl Acad. Sci. USA 92, 7627-7631.
103. Ke, S.-H., Taschias, K., Lamba, D., Bode, W. & Madison, E.L. (1997) Identification of a hydrophobic exosite on tissue-type plasminogen activator that modulates specificity for plasminogen. J. Biol. Chem. 272, 1811-1816.
104. Taschias, K. & Madison, E.L. (1996) Convening tissue-type plasminogen activator into a zymogen. J. Biol. Chem. 271, 28749-28752.
105. 156. J. Biol. Chem. 272, 28-31.
106. Bringmann, P., Bruber, D., Liese, A., Toschi, L., Kratzschmar, J., Schleuning, W.D. & Donner, P. (1995) Structural features mediating fibrin selectivity of vampire bat plasminogen activators. J. Biol. Chem. 270, 25596-25603.
107. Huber, R. & Bode, W. (1978) Structural basis of the activation and action of trypsin. Acc. Chem. Res. 11, 114-122.
108. Bode, W. & Renatus, M. (1997) Tissue-type plasminogen activator: variants and crystal/solution structures demarcate structural determinants of function. Curr. Opin. Struct. Biol. 7, 865-872.
109. Schellenberger, V., Braune, K., Hofmann, H.-J. & Jakubke, H.-D. (1991) The specificity of chymotrypsin. A statistical analysis of hydrolysis data. Eur. J. Biochem. 199, 623-636.
110. McGrath, M.E., Gillmor, S.A. & Fletterick, R.J. (1995) Ecotin: lessons on survival in a protease-filled world. Protein Sci. 4, 141-148.
111. Scheidig, A.J., Hynes, T.R., Pelletier, L.A., Wells, J.A. & Kossiakoff, A.A. (1997) Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid β-precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities. Protein Sci. 6, 1806-1824.
112. Brain, S.D. & Williams, T.J. (1988) Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature 335. 73-75.
113. Chandrasekharan, U.M., Sanker, S., Glynias, M.J., Karuik, S.S. & Husain, A. (1996) Angiotensin II-forming activity in a reconstructed ancestral chymase. Science 271, 502-505.
114. McGrath, M.E., Mirzadegan, T. & Schmidt, B.F. (1997) Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase at 1.9 Å. Biochemistry 36, 14318-14324.
115. Urata, H., Karnik, S.S., Graham, R.M. & Husain, A. (1993) Dipeptide processing activates recombinant human prochymase. J. Biol. Chem. 268, 24318-24322.
116. 18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B. Protein Sci. 4, 1985-1997.
117. 1 residues in serine proteinase inhibitors undergo large pK shifts on complex formation. J. Biol. Chem. 270, 1-4.
118. Hedstrom, L., Szilagyi, L. & Rutter, W.J. (1992) Converting trypsin to chymotrypsin: the role of surface loops. Science 255, 1249-1253.
119. Perona, J.J., Hedstrom, L., Rutter, W.J. & Fletterick, R.J. (1995) Structural origins of substrate discrimination in trypsin and chymotrypsin. Biochemistry 34, 1489-1499.
120. Hedstrom, L., Perona, J.J. & Rutter, W.J. (1994) Converting trypsin to chymotrypsin: residue 172 is a substrate specificity determinant. Biochemistry 26, 8757-8763.
121. Hedstrom, L., Farr-Jones, S., Kettner, C.A. & Rutten W.J. (1994) Converting trypsin to chymotrypsin: ground-state binding does not determine substrate specificity. Biochemistry 33, 8764-8769.
122. Willett, W.S., Brinen, L.S., Fletterick, R.J. & Craik, C.S. (1996) Delocalizing trypsin with metal activation. Biochemistry 35, 5992-5998.
123. Gron, G.A., Meldal, M. & Breddam, K. (1992) Extensive comparison of the substrate preferences of two subtilisins as determined with peptide substrates which are based on the principle of intramoleular quenching. Biochemistry 31, 6011-6018.
124. Harper, J.W., Cook, R.R., Roberts, C.J., McLaughlin, B.J. & Powers, J.C. (1984) Active site mapping of the serine proteases human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II, bovine chymotrypsin Act and S. aureus protease V-8 using tripeptide thiobenzyl ester substrates. Biochemistry 23, 2995-3002.
125. Huber, R., Bode, W., Kulda, D., Kohl, U. & Ryan, C.A. (1975) The structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Structure of the anhydro-trypsin-inhibitor complex. Biophys. Struct. Mech. 1, 189-201.
126. Rasmussen, B., Wiberg, F.C., Flodgaard, H.J. & Larsen, I.K. (1997) Structure of HBP, a multifunctional protein with a serine proteinase fold. Nat. Struct. Biol. 4, 265-268.
127. Baggiolini, M., Bretz, U., Dewald, B. & Feigenson, M.E. (1978) The polymorphonuclear leukocyte. Agents Actions 8, 3-10.
128. Fujinaga, M., Chernaia, M.M., Halenbeck, R., Koths, K. & James, M.N.G. (1996) The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies. J. Mol. Biol. 261, 267-278.
129. Kam, C.M., Kerrigan. J.E., Dolman, K.M., Von Goldschmeding, R., dem Borne, A.E. & Powers, J.C. (1992) Substrate and inhibitor studies on proteinase 3. FEBS Lett. 297, 119-123.
130. Tsu, C.A., Perona, J.J., Fletterick, R.J. & Craik, C.S. (1997) Structural basis for the broad substrate specificity of Fiddler crab collagenolytic serine protease I. Biochemistry 36, 5393-5401.
131. 2 a Janus-faced proteinase with two opposite specificities. EMBO J. 15, 5481-5491.
132. Tsu, C.A., Perona, J.J., Schellenberger, V., Turck, C.W. & Craik, C.S. (1994) The substrate specificity of Uca pugilator collagenolytic serine protease 1 correlates with the bovine type I collagen cleavage sites. J. Biol. Chem. 269, 19565-19572.
133. Perona, J.J., Tsu, C.A., Craik, C.S. & Fletterick, R.J. (1997) Crystal structure of an ecotin-collagenase complex suggests a model for recognition and cleavage of the collagen triple helix. Biochemistry 36, 5381-5392.
134. Wells, J.A., Powers, D.B., Bott, R.R., Graycar, T.P. & Estell, D.A. (1987) Designing substrate specificity by protein engineering of electrostatic interactions. Proc. Natl Acad. Sci. USA 84, 1219-1223.
135. Ballinger, M.D., Tom, J. & Wells, J.A. (1995) Designing subtilisin BPN′ to cleave substrates containing dibasic residues. Biochemistry 34, 13312-13319.
136. Ballinger, M.D., Tom, J. & Wells, J.A. (1996) Furilisin: a variant of subtilisin BPN′ engineering for cleaving tribasic substrates. Biochemistry 35, 13579-13585.
137. Wells, J.A., Cunningham, B.C., Graycar, T.P. & Estell, D.A. (1987) Recruitment of substrate-specificity properties from one enzyme into a related one by protein engineering. Proc. Natl Acad. Sci. USA 84, 5167-5171.
138. Fujinaga, M., Delbaere, L.T.J., Brayer, G.D. & James, M.N.G. (1985) Refined structure of α-lytic protease at 1.7 Å. resolution. Analysis of hydrogen bonding and solvent structure. J. Mol. Biol. 184, 479-502.
139. Delbaere, L.T.J., Brayer, G.D. & James, M.N.G. (1979) The 2.8 Å resolution structure of Streptomyces griseus protease B and its homology with α-chymotrypsin and Streptomyces griseus protease A. Can. J. Biochem. 57, 135-144.
140. Fersht, A.R., Shi, J.P., Knill-Jones, J., Lowe, D.M., Wilkinson, A.J., Blow, D.M., Brick, P., Carter, P., Waye, M.M.Y. & Winter, G. (1985) Hydrogen bonding and biological specificity analysed by protein engineering. Nature 314, 235-238.
141. Bone, R., Silen, J.L. & Agard, D.A. (1989) Structural plasticity broadens the specificity of an engineered protease. Nature 339, 191-195.
142. 1 binding site of glutamic acid-specific protease from Streptomyces griseus. Protein Sci. 5, 2266-2275.
143. Breddam, K. & Meldal, M. (1992) Substrate preferences of glutamic-acid-specific endopeptidases assessed by synthetic peptide substrates based on intramolecular fluorescence quenching. Eur. J. Biochem. 206, 103-107.
144. Jewell, D.A., Swietnicki, W., Dunn, M. & Malcolm, B.A. (1992) The 3C cysteine-protease from hepatis A virus. Biochemistry 31, 7862-7869.
145. Redpath, M.B., Foster, T.J. & Bailey, C.J. (1991) The role of the serine protease active site in the mode of action of epidermolytic toxin of Staphylococcus aureus. FEMS Microbiol. Lett. 65, 151-155.
146. Prevost, G., Rifai, S., Chaix, M.L. & Piemont, Y. (1991) Functional evidence that the Ser-195 residue of staphylococcal exfoliative toxin A is essential for biological activity. Infect. Immun. 59, 3337-3339.
147. Vath, G.M., Earhart, C.A., Rago, J.V., Kim, M.H., Bohach, G.A., Schlievert, P.M. & Ohlendoff, D.H. (1997) The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease. Biochemistry 36, 1559-1566.
148. Hopfner, K.-P., Kopetzki, E., Kreße, G.-B., Bode, W., Huber, R. & Engh, R.A. (1998) New enzyme lineages by subdomain shuffling. Proc. Natl Acad. Sci. USA 95, 9813-9818.
149. Wallace, A.C., Laskowski, R.A. & Thornton, J.M. (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8, 127-134.
150. Schechter, I. & Berger, M. (1967) On the size of the active site in proteases. Biochem. Biophys. Res. Commun. 27, 157-162.
151. Fujinaga, M., Sielecki, A.R., Read, R.J., Ardelt, W., Laskowski, M. Jr & James, M.N.G. (1987) Crystal and molecular structures of the complex of alpha-chymotrypsin with its inhibitor turkey ovomucoid third domain at 1.8 Å resolution. J. Mol. Biol. 195, 397-418.
152. Iversen, L.F., Kastrup, J.S., Bjorn, S.E., Rasmussen, P.B., Wiberg, F.C., Flodgaard, H.J. & Larsen, I.K. (1997) Structure of HBP, a multifunctional protein with a serine proteinase fold. Nat. Struct. Biol. 4, 265-268.
153. McGrath, M.E., Vasquez, J.R., Craik, C.S., Yang, A.S., Honig, B. & Fletterick, R.J. (1992) Perturbing the polar environment of Asp102 in trypsin: consequences of replacing conserved Ser214. Biochemistry 31, 3059-3064.
154. Navia, M.A., Mc Keever, B.M., Springer, J.P., Lin, T.-Y., Williams, H.R., Fluder, E.M., Dorn, C.P. & Hoogsteen, K. (1989) Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84 Å resolution. Proc. Natl Acad. Sci. USA 86, 7-11.
155. + ion binding site of thrombin. Biophys. Chem. 63, 185-200.
156. Bode, W., Greyling, H.J., Huber, R., Otlewski, J. & Wilusz, T. (1989) The refined 2.0 Å X-ray crystal structure of the complex formed between bovine β-trypsin and CMTI-I, a trypsin inhibitor from squash seeds (Cucurbita maxima): topological similarity of the squash seed inhibitors with the carboxypeptidase A inhibitor from potatoes. FEBS Lett. 242, 285-292.
157. Takahashi, L.H., Radhakrishnan, R., Rosenfield, R.E. Jr, Meyer, E.F. Jr & Trainor, D.A. (1989) Crystal structure of the covalent complex formed by a peptidyl alpha,alpha-difluoro-beta-keto amide with porcine pancreatic elastase at 1.78 Angstroms resolution. J. Am. Chem. Soc. 111, 3368-3374.
158. Remington, S.J., Woodbury, R.G., Reynolds, R.A., Matthews, B.W. & Neurath, H. (1988) The stracture of rat mast cell protease II at 1.9 Å resolution. Biochemistry 27, 8097-8105.
159. James, M.N.G., Sielecki, A.R., Brayer, G.D., Delbaere, L.T.J. & Bauer, C.-A. (1980) Structures of product and inhibitor complexes of Streptomyces griseus protease A at 1.8 Å resolution. A model for serine protease catalysis. J. Mol. Biol. 144, 43-88.
160. Read, R.J., Fujinaga, M., Sielecki, A.R. & James, M.N.G. (1983) Structure of the complex of Streptomyces griseus protease B and the third domain of the turkey ovomucoid inhibitor at 1.8 Å resolution. Biochemistry 22, 4420-4433.
161. Read, R.J. & James, M.N.G. (1988) Refined crystal structure of Streptomyces griseus trypsin at 1.7 Å resolution. J. Mol. Biol. 200, 523-551.
162. Jones, T.A., Zou, J.-Y., Cowan, S.W. & Kjeldgaard, M. (1991) Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A47, 110-119.